Cipla gets nod for generic version of Shire’s Firazyr

Pharma major Cipla has announced that the company has received the final approval for its Abbreviated New Drug Application (ANDA) for Icatibant Injectable 30mg/3mL from the United States Food and Drug Administration (US FDA).

Cipla’s Icatibant Injectable Pre-Filled Syringe 30mg/3mL is AP-rated generic version of Shire’s Firazyr.The purpose of the Icatibant injection is for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.

  • Related Posts

    Muradnagar Police Bust Fake Liver-52 DS Herbal Medicine Racket: Three Arrested

    Ghaziabad: Uttar Pradesh Police, in a joint operation by Muradnagar police and the Dehat SWAT team, have cracked a counterfeit herbal medicine syndicate producing fake versions of Himalaya Wellness Company’s popular…

    Massive Eskuf haul seized from train in Agartala

    Agartala:  In yet another major drug bust on the railway route, a large consignment of Eskuf cough syrup was seized at Badharghat Railway Station, once again exposing the growing menace…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Muradnagar Police Bust Fake Liver-52 DS Herbal Medicine Racket: Three Arrested

    Muradnagar Police Bust Fake Liver-52 DS Herbal Medicine Racket: Three Arrested

    Massive Eskuf haul seized from train in Agartala

    Massive Eskuf haul seized from train in Agartala

    Vadodara Police Seize Illegal Steroids and Testosterone Injections from Russia and Austria in Bodybuilding Shop Raid

    Vadodara Police Seize Illegal Steroids and Testosterone Injections from Russia and Austria in Bodybuilding Shop Raid

    35 drugs manufactured in Telangana fail CDSCO quality checks

    35 drugs manufactured in Telangana fail CDSCO quality checks

    Delhi govt inspects 25 firms, collects 55 samples in crackdown on spurious anticancer drugs

    Delhi govt inspects 25 firms, collects 55 samples in crackdown on spurious anticancer drugs

    ‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head

    ‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head